Web11 jan. 2006 · We look forward to working with the Miikana team and to incorporating the MKC-1, aurora kinase, and HDAC programs into our pipeline." Under the terms of the … WebMiikana Therapeutics Inc. (Corporation# 6007694) is a federal corporation entity registered with Corporations Canada. The incorporation date is July 26, 2002. The principal …

Miikana Therapeutics Inc - Company Profile and News

WebContact us Creating a positive impact on global health. We champion innovative technology, transformative business and product development, and a strategic network of worldwide assets. Your Product Lifecycle Partner Problem Many start-ups to mid-size companies have a crucial need for access to the right talent and expertise at just the right time. WebIn December, 2005, Miikana was sold to Entremed for $21 million plus milestones. Since 2003, I have focused my attention on open source synthetic biology. Part of my broad education and outreach agenda includes the founding of … jeep grand cherokee three car seats

Miikana Therapeutics - Funding, Financials, Valuation & Investors

WebMiikana Therapeutics Inc., a biopharmaceutical company with joint research operations in the Bay Area, California and Toronto, Canada, announced today that it had completed a … WebMiikana Therapeutics was developing small molecules to treat various cancer. Its pipeline includes clinical and pre-clinical drug candidates. Its lead candidate, MKC-1, is an orally … Web1 jun. 2013 · Miikana Therapeutics Inc. Jun 2002 - Feb 2003 9 months. Co-founder of Toronto based start up company specializing in cancer … owner secret recipe